Allianz Biotechnologie - A - EUR/  DE0008481862  /

The Fund aims to generate long-term capital growth. We invest at least 70% of the Fund's assets directly or via derivatives in equities and comparable securities of companies whose principal activity is researching, developing and producing biotechnological goods, processes or services. We may invest up to 10% of the Fund's assets in Chinese A-shares. Moreover, investments can also be made in other equities and comparable securities. Up to 30% of the Fund's assets may also be invested in money market instruments or bank deposits. A maximum of 10% of the Fund's assets may be invested in target funds (UCITS and/or UCI).

The Fund aims to generate long-term capital growth.